Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Dermatologic 1

Conditions

Melanoma 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 640pembrolizumab 570Magnetic Resonance Spectroscopy 550Carboplatin 430Cyclophosphamide 382Cisplatin 376Biopsy 364Paclitaxel 312Nivolumab 310Gemcitabine 302Radiotherapy 275Bevacizumab 243Dexamethasone 213fludarabine 209Docetaxel 193durvalumab 182atezolizumab 179Oxaliplatin 173Rituximab 168Fluorouracil 168venetoclax 167Pemetrexed 165Doxorubicin 163Radiation 161Capecitabine 161Radiosurgery 149Etoposide 138Ipilimumab 136Leucovorin 134Lenalidomide 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ketones × 90 days × Clear all
NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡